Last reviewed · How we verify

Selacryn (tienilic acid)

FDA-approved active ✓ Verified May 2026 Quality 15/100

Selacryn (generic name: tienilic acid) is a tienilic acid drug. It is currently FDA-approved (first approved 1979) for Hypertensive disorder.

Selacryn, also known as ticrynafen, is a small molecule drug with an unknown mechanism of action. It was a loop diuretic and uricosuric agent used to treat hypertension, but was withdrawn from the market in 1982 due to reports of a link between its use and hepatitis.

At a glance

Generic nametienilic acid
Drug classtienilic acid
Therapeutic areaCardiovascular
PhaseFDA-approved
First approval1979

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Selacryn

What is Selacryn?

Selacryn (tienilic acid) is a tienilic acid drug, indicated for Hypertensive disorder.

What is Selacryn used for?

Selacryn is indicated for Hypertensive disorder.

What is the generic name of Selacryn?

tienilic acid is the generic (nonproprietary) name of Selacryn.

What drug class is Selacryn in?

Selacryn belongs to the tienilic acid class. See all tienilic acid drugs at /class/tienilic-acid.

When was Selacryn approved?

Selacryn was first approved on 1979.

What development phase is Selacryn in?

Selacryn is FDA-approved (marketed).

Related